AbbVie (ABBV) Interest Expenses (2012 - 2016)

AbbVie (ABBV) has 5 years of Interest Expenses data on file, last reported at $245.0 million in Q2 2016.

• Quarterly Interest Expenses rose 42.44% year-over-year to $245.0 million in Q2 2016, while the trailing twelve-month figure through Mar 2017 was $245.0 million (down 69.45% YoY) and the FY2015 annual result came in at $719.0 million, up 67.6% from the prior year.
• Interest Expenses advanced to $245.0 million in Q2 2016 per ABBV's latest filing, from $215.0 million in the prior quarter.
• Across five years, Interest Expenses topped out at $245.0 million in Q2 2016 and bottomed at $10.0 million in Q3 2012.
• The 5-year median for Interest Expenses is $113.0 million (2012), against an average of $125.8 million.
• Peak annual rise in Interest Expenses reached 650.0% in 2013, while the deepest fall reached 21.28% in 2013.
• Tracing ABBV's Interest Expenses over 5 years: stood at $94.0 million in 2012, then fell by 21.28% to $74.0 million in 2013, then jumped by 87.84% to $139.0 million in 2014, then surged by 49.64% to $208.0 million in 2015, then rose by 17.79% to $245.0 million in 2016.
• Per Business Quant, the three latest ABBV Interest Expenses figures stand at $245.0 million (Q2 2016), $215.0 million (Q1 2016), and $208.0 million (Q4 2015).

Peer Comparison